TO THE EDITOR: With great interest we have read the article of Chen et al 1 on the effects of Lactobacillus casei Shirota on stool consistency in constipated patients. Apart from an improvement of constipation-related symptoms, they also showed a clear interaction between baseline Bristol stool form scale (BSFS) consistency levels and baseline relative abundance of Lachnoclostridium, Lachnospiraceae UCG-004, Pseudobutyrivibrio, and Ruminiclostridum 5. In line with this observation, an increasing number of studies use BSFS to correct for differences in fecal consistency in microbiome analyses. The generalizability of this patient-reported tool is however unclear. The BSFS has been developed in the early 90s as a surrogate marker of whole-gut transit time (WGTT) and has been recommended for the use as such in both clinical and research settings. 2,3 Although initially designed for WGTT, the BSFS is often used as a measure of stool consistency.
